HK's PacBridge Capital invests $9.46m in Canada's Contextual Genomics

Hong Kong. Image: Pixabay

PacBridge Capital Partners (HK) Limited, a Hong Kong-based investment firm, has committed to a C$12 million ($9.46 million) facility to fund Contextual Genomics Inc., a Canadian cancer genomics company.

Sue Paish, former President and CEO of LifeLabs Medical Laboratory Services, and James Lumsdaine of PacBridge will join the Contextual Genomics’ Board of Directors, post investment.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter